Schizoaffective Disorder
Late Teen Emotional Stability Inversely Tied to Mental Illness
June 02, 2017Emotional stability assessed in late adolescence is inversely associated with serious mental illness.
Greater Cognitive Decline in Individuals at Risk for Bipolar Disorder With Obesity
May 15, 2017The burden of illness associated with bipolar disorder warrants early preemption.
Negative Outcomes in Bipolar, Schizoaffective Disorder Linked to Irritability
May 15, 2017Irritability may have wide-ranging impacts on symptomatic, functional, and social elements of quality of life.
Underlying Mechanism of Auditory Impairment in Schizophrenia Reveals Potential Therapeutic Path
December 12, 2016Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading.
The Effect of Cognitive Remediation Training on Functional Connectivity and Social Cognition in Schizophrenia
October 13, 2016Study provides further evidence for the effects of cognitive enhancement intervention on brain functional connectivity and cognitive performance in patients with schizophrenia.
Effort Allocation Influences Upon Cognition in Schizophrenia
October 06, 2016Researchers studied social cognition and social problem solving in patients with schizophrenia by employing a validated test designed to assess emotion recognition abilities.
White Matter Abnormalities and Clinical Symptom Severity in Schizophrenia
September 28, 2016New findings provide an insight about the association between white matter microstructure and the severity of schizophrenia clinical symptoms.
How Reliable Are Patient-reported Outcomes in Schizophrenia?
August 31, 2016The primary outcome in this study was reliability of patient-ratings on subjective well-being.
Cortical Molecular Markers Differentiate Psychotic, Bipolar Disorders
August 11, 2016The researchers quantified the transcript levels of GAD67, parvalbumin, somastatin, and Lhx6 in the prefrontal cortex.
Molecular Abnormalities in the Hippocampus in Schizophrenia
July 06, 2016Post mortem examination of human brain samples derived from individuals diagnosed with schizophrenia revealed widespread synaptic alterations in CA1 hippocampal subfield.
Early Biomarkers Identified in Schizophrenia Preclinical Model
July 06, 2016New findings provide insights about the neuroanatomy and neurophysiology of schizophrenia.
An Overview of Psychotic Disorders and Treatment
June 22, 2015Antipsychotics have been effective in the treatment of psychotic disorders, but clinicians must be cognizant of side effects.
Psychosis Infrequently Associated With Violent Crimes
June 15, 2015Only 12% of violent incidents committed by high-risk psychiatric patients were preceded by hallucinations and delusions.
Naltrexone Promotes Weight Loss in Women With Schizophrenia
August 11, 2014Antipsychotic-related weight gain mitigated when drug used to treat alcohol dependency given to women suffering from schizophrenia.
Hippocampal Volume Tied to Psychotic Disorders
June 05, 2014Abnormalities observed in hippocampal subfields tied to memory-related processes
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder